Implanted cardiac resynchronization device

Results: 62



#Item
51REVERSE & RAFT Panel Questions

REVERSE & RAFT Panel Questions

Add to Reading List

Source URL: www.fda.gov

Language: English
52Panel Questions Circulatory System Devices Panel Meeting December 7, 2011 P010031 / S232 Expanded Indications for Medtronic Cardiac Resynchronization Therapy Defibrillators

Panel Questions Circulatory System Devices Panel Meeting December 7, 2011 P010031 / S232 Expanded Indications for Medtronic Cardiac Resynchronization Therapy Defibrillators

Add to Reading List

Source URL: www.fda.gov

Language: English
53REVERSE / RAFT - P010031-S232

REVERSE / RAFT - P010031-S232

Add to Reading List

Source URL: www.fda.gov

Language: English
54Brief Summary of the Circulatory System Devices Panel Meeting – January 26, 2011

Brief Summary of the Circulatory System Devices Panel Meeting – January 26, 2011

Add to Reading List

Source URL: www.fda.gov

Language: English
55Base SubmissionTemplate_R00

Base SubmissionTemplate_R00

Add to Reading List

Source URL: www.fda.gov

Language: English
56Microsoft Word - 25Oct11 Proposed Summary of Safety and Effectiveness Document.doc

Microsoft Word - 25Oct11 Proposed Summary of Safety and Effectiveness Document.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
57REVERSE & RAFT - FDA Executive Summary

REVERSE & RAFT - FDA Executive Summary

Add to Reading List

Source URL: www.fda.gov

Language: English
58Attachment G: Post Approval Study (PAS) Proposal

Attachment G: Post Approval Study (PAS) Proposal

Add to Reading List

Source URL: www.fda.gov

Language: English
59Verstrekkers van implantaten - Omzendbrief[removed]

Verstrekkers van implantaten - Omzendbrief[removed]

Add to Reading List

Source URL: www.riziv.fgov.be

Language: English - Date: 2010-09-27 05:33:33
60Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English